Women's Trust in and Use of Information Sources in the Treatment of Menopausal Symptoms

Andrist, 1998, The impact of media attention, family history, politics and maturation on women's decisions regarding hormone replacement therapy, Health Care for Women International, 19, 243, 10.1080/073993398246403 Ayerst Laboratories, 2002 Churchill, 2004 Clinkingbeard, 1999, Women's knowledge about menopause, hormone replacement therapy (HRT), and interactions with healthcare providers: an exploratory study, Journal of Women's Health and Gender-Based Medicine, 8, 1097, 10.1089/jwh.1.1999.8.1097 Comrey, 1992 Dillman, 2000 Frewer, 1996, What determines trust in information about food-related risks? Underlying psychological constructs, Risk Analysis, 16, 473, 10.1111/j.1539-6924.1996.tb01094.x Garamszegi, 1998, Menopausal status: Subjectively and objectively defined, Journal of Psychosomatic Obstetrics and Gynaecology, 19, 165, 10.3109/01674829809025694 Gilson, 2003, Trust and the development of health care as a social institution, Social Science & Medicine, 56, 1453, 10.1016/S0277-9536(02)00142-9 Grady, 2002, Cardiovascular disease outcomes during 6.8 years of hormone therapy. Heart and estrogen/progestin replacement study follow up (HERS II), JAMA, 288, 321, 10.1001/jama.288.1.49 Griffiths, 1995, Women's decisions about whether or not to take hormone replacement therapy: Influence of social and medical factors, The British Journal of General Practice, 45, 477 Griffiths, 1999, Women's control and choice regarding HRT, Social Science and Medicine, 49, 469, 10.1016/S0277-9536(99)00141-0 Guillemin, 1999, Managing menopause: A critical feminist engagement, Scandinavian Journal of Public Health, 27, 273 Hoffman, 2005, Changes in women's attitudes towards and use of hormone therapy after HERS and WHI, Maturitas, 52, 11, 10.1016/j.maturitas.2005.06.003 Huston, 2003 Huston, 2006, Use, intentions, and beliefs about hormone replacement therapy in women with and without diabetes, Maturitas, 55, 58, 10.1016/j.maturitas.2006.01.004 Ingebretsen, M. (2002, December 30). Top health stories of '02: the strange and important. The Wall Street Journal [online version]. Available from: http://online.wsj.com/article/0,SB104117561424046953,00.html. Keating, 1999, Use of hormone replacement therapy by postmenopausal women in the United States, Annals of Internal Medicine, 130, 545, 10.7326/0003-4819-130-7-199904060-00002 Kennedy, 2003, Patients are expert in their own field, British Medical Journal, 326, 1276, 10.1136/bmj.326.7402.1276 Korsgaard, 2002, Trust in the face of conflict: The role of managerial trustworthy behavior and organizational context, Journal of Applied Psychology, 87, 312, 10.1037/0021-9010.87.2.312 Ma, 2006, US women desire greater professional guidance on hormone and alternative therapies for menopause symptom management, Menopause, 13, 506, 10.1097/01.gme.0000179047.00748.53 Manson, 2007, Estrogen therapy and coronary-artery calcification, New England Journal of Medicine, 356, 2591, 10.1056/NEJMoa071513 McCrea, 1983, The politics of menopause: the “discovery” of a deficiency disease, Social Problems, 31, 111, 10.1525/sp.1983.31.1.03a00080 McIntosh, 2005, Effects of media coverage of Women's Health Initiative study on attitudes and behavior of women receiving hormone replacement therapy, American Journal of Health-System Pharmacy, 62, 69, 10.1093/ajhp/62.1.69 Mechanic, 1996, Changing medical organization and the erosion of trust, The Milbank Quarterly, 74, 171, 10.2307/3350245 Mechanic, 1998, Public trust and initiatives for new health care partnerships, The Milbank Quarterly, 76, 281, 10.1111/1468-0009.00089 Robinson, 1996, Can postmenopausal hormone replacement improve plasma lipids in women with diabetes?, Diabetes Care, 19, 480, 10.2337/diacare.19.5.480 Schonberg, 2005, After the Women's Health Initiative: Decision making and trust of women taking hormone therapy, Womens Health Issues, 15, 187, 10.1016/j.whi.2005.03.003 Shojania, K.G., Mariani, S.M., & Lundberg, G.D. (2002). MedGenMed's selection of the top 10 medical/health stories of 2002. Available from: http://www.medscape.com/viewarticle/446310. Accessed December 24, 2002. Slovic, 1992, Perceptions of risk: Reflections on the psychometric paradigm, 117 Stafford, 1997, Low rates of hormone replacement in visits to United States primary care physicians, American Journal of Obstetrics and Gynecology, 177, 381, 10.1016/S0002-9378(97)70202-3 Suter, 2007, Women's approaches to evaluating complementary and alternative therapies for menopausal symptoms, Canadian Family Physician, 53, 84 Thompson, 1995, Estrogen replacement therapy in practice: Trends and issues, American Journal of Obstetrics and Gynecology, 173, 990, 10.1016/0002-9378(95)90248-1 Tio, 2007, Ascertaining consumer perspectives of medication information sources using a modified repertory grid technique, Pharmacy World & Science, 29, 73, 10.1007/s11096-006-9076-9 Udell, 2006, Effect of the Women's Health Initiative on osteoporosis therapy and expenditure in Medicaid, Journal of Bone and Mineral Research, 21, 765, 10.1359/jbmr.060119 Watkins, 2001, Dispensing with aging: Changing rationales for long-term hormone replacement therapy, 1960-2000, Pharmacy in History, 43, 23 Whitener, 1998, Managers as initiators of trust: An exchange relationship framework for understanding managerial trustworthy behavior, Academy of Management Review, 23, 513, 10.5465/amr.1998.926624 2002, Risks and benefits of estrogen plus progestin in healthy postmenopausal women, Journal of the American Medical Association, 288, 321, 10.1001/jama.288.3.321